(Q72199028)

English

The reversibility of pulmonary hypertension in patients with cystic fibrosis. Observations on the effects of tolazoline hydrochloride

scientific article published on 01 January 1967

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 October 2019

title

The reversibility of pulmonary hypertension in patients with cystic fibrosis. Observations on the effects of tolazoline hydrochloride (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

pulmonary hypertension

1 reference

Kelminson LL

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 October 2019

Cotton EK

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 October 2019

Vogel JH

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 October 2019

language of work or name

English

0 references

publication date

1 January 1967

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 October 2019

volume

39

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 October 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 October 2019

page(s)

24-35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 October 2019

Identifiers

PubMed publication ID

6016228

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6016228

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6016228%20AND%20SRC:MED&resulttype=core&format=json

(Q72199028)

The reversibility of pulmonary hypertension in patients with cystic fibrosis. Observations on the effects of tolazoline hydrochloride

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)